These hurdles exist because state Medicaid budgets cant afford to cover everyone who would benefit from the drug.

Previously, it was only indicated for weight management.

Its important to know that coverage can change every year.

A close up of a pharmacist’s hand holding a box of a 0.25 mg Wegovy injection medication

Getty Images /Bloomberg/ Contributor

Milliman.GLP-1 agonists in Medicaid: utilization, growth and management.

2022;179(4):625-641. doi:10.1111/bph.15677